Byron Law
Family Medicine · Kansas City, MONPI 1679570329
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,366 and has fallen 96.7% since, to $45 in 2023.
Across 220 payments — averaging $14.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$561
- Amarin Pharma, Inc.$398
- Novo Nordisk$384
- Amgen$351
- AbbVie$255
- Pfizer$232
- plus $942 from 26 others
What the payments were for
- Food & beverage$3,122100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $561 |
| Amarin Pharma, Inc. | 31 | $398 |
| Novo Nordisk | 32 | $384 |
| Amgen | 26 | $351 |
| AbbVie(2 entities) | 19 | $255 |
| Pfizer | 21 | $232 |
| Johnson & Johnson | 10 | $124 |
| Boehringer Ingelheim | 7 | $90 |
| Astellas Pharma US Inc | 4 | $71 |
| Lilly USA, LLC | 5 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| GSK | 4 | $59 |
| Novartis | 4 | $57 |
| E.r. Squibb & Sons, L.L.C. | 4 | $52 |
| Sanofi-aventis U.S. LLC | 1 | $45 |
| Medtronic | 1 | $43 |
| Merck | 3 | $37 |
| Scilex Pharmaceuticals Inc. | 3 | $35 |
| Roche Diagnostics Corporation | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Organogenesis Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,122 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Kansas City
- Blair ThedingerKansas City$71K
- Jon MattsonKansas City$53K
- Meredith LevineKansas City$26K
- Kelly SandriKansas City$17K
- Michael SimanovskyKansas City$16K
- Teresa MarshallKansas City$16K
- Nora GomezKansas City$15K
- Julie AlvarezKansas City$15K
- Neal MooreKansas City$14K
- Stephen AdamsSpringfield$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.